cancer stage
Recently Published Documents


TOTAL DOCUMENTS

1127
(FIVE YEARS 353)

H-INDEX

51
(FIVE YEARS 8)

2088 ◽  
Vol 11 (1) ◽  
pp. 98-103
Author(s):  
David Wiljer ◽  
Lisa Le ◽  
Heather Logan ◽  
David Neligan ◽  
James Brierley
Keyword(s):  

PLoS ONE ◽  
2022 ◽  
Vol 17 (1) ◽  
pp. e0262468
Author(s):  
Susanna Hilda Hutajulu ◽  
Yayi Suryo Prabandari ◽  
Bagas Suryo Bintoro ◽  
Juan Adrian Wiranata ◽  
Mentari Widiastuti ◽  
...  

Purpose To investigate factors associated with delays in presentation and diagnosis of women with confirmed breast cancer (BC). Methods A cross-sectional study nested in an ongoing prospective cohort study of breast cancer patients at Dr Sardjito Hospital, Yogyakarta, Indonesia, was employed. Participants (n = 150) from the main study were recruited, with secondary information on demographic, clinical, and tumor variables collected from the study database. A questionnaire was used to gather data on other socioeconomic variables, herbal consumption, number of healthcare visits, knowledge-attitude-practice of BC, and open-ended questions relating to initial presentation. Presentation delay (time between initial symptom and first consultation) was defined as ≥3 months. Diagnosis delay was defined as ≥1 month between presentation and diagnosis confirmation. Impact on disease stage and determinants of both delays were examined. A Kruskal-Wallis test was used to assess the length and distribution of delays by disease stage. A multivariable logistic regression analysis was conducted to explore the association between delays, cancer stage and factors. Results Sixty-five (43.3%) patients had a ≥3-month presentation delay and 97 (64.7%) had a diagnosis confirmation by ≥1 month. Both presentation and diagnosis delays increased the risk of being diagnosed with cancer stage III-IV (odds ratio/OR 2.21, 95% CI 0.97–5.01, p = 0.059 and OR 3.03, 95% CI 1.28–7.19, p = 0.012). Visit to providers ≤3 times was significantly attributed to a reduced diagnosis delay (OR 0.15, 95% CI 0.06–0.37, p <0.001), while having a family history of cancer was significantly associated with increased diagnosis delay (OR 2.28, 95% CI 1.03–5.04, p = 0.042). The most frequent reasons for delaying presentation were lack of awareness of the cause of symptoms (41.5%), low perceived severity (27.7%) and fear of surgery intervention (26.2%). Conclusions Almost half of BC patients in our setting had a delay in presentation and 64.7% experienced a delay in diagnosis. These delays increased the likelihood of presentation with a more advanced stage of disease. Future research is required in Indonesia to explore the feasibility of evidence-based approaches to reducing delays at both levels, including educational interventions to increase awareness of BC symptoms and reducing existing complex and convoluted referral pathways for patients suspected of having cancer.


2022 ◽  
Author(s):  
Jennifer Richmond ◽  
Megan Hollister ◽  
Cato M. Milder ◽  
Ann G. Schwartz ◽  
Jeffrey D. Blume ◽  
...  

2022 ◽  
pp. 1218-1223
Author(s):  
Deepak Chatha ◽  
Alankrita Aggarwal ◽  
Rajender Kumar

The mortality rate among women is increasing progressively due to cancer. Generally, women around 45 years old are vulnerable from this disease. Early detection is hope for patients to survive otherwise it may reach to unrecoverable stage. Currently, there are numerous techniques available for diagnosis of such a disease out of which mammography is the most trustworthy method for detecting early cancer stage. The analysis of these mammogram images are difficult to analyze due to low contrast and nonuniform background. The mammogram images are scanned and digitized for processing that further reduces the contrast between Region of Interest and background. Presence of noise, glands and muscles leads to background contrast variations. Boundaries of suspected tumor area are fuzzy & improper. Aim of paper is to develop robust edge detection technique which works optimally on mammogram images to segment tumor area. Output results of proposed technique on different mammogram images of MIAS database are presented and compared with existing techniques in terms of both Qualitative & Quantitative parameters.


2021 ◽  
Author(s):  
Zahraa Ahmad Abul ◽  
Abbas Alsalman

This research focuses on examining the use and non-use of information resources among cancer patients. Non-seekers’ information-seeking behavior is analyzed in this research to determine the causes and symptoms of their non-seeking of health knowledge. Cancer patients use a variety of information resources such as the Internet, social media, and medical databases, in order to satisfy their needs. Studies showed that patients’ knowledge of their cancer stage might help them in making their care and treatment choices. Focus groups are commonly used in health research to explore the perspectives of patients or health care professionals; relatively few studies consider methodological aspects in this specific context. The purpose of this research is to investigate the information needs of cancer patients, and to find out reasons for the lack of cancer stage knowledge and desire for information after diagnosis. Expected findings include personal, situational, and psychological reasons, such as: low health literacy, low usage of health information, health instructions and the ways to increase patient awareness of the benefits and ways of seeking information.


2021 ◽  
Author(s):  
ByoungJun Jeon ◽  
Hyo Gi Jung ◽  
Sang Won Lee ◽  
Gyudo Lee ◽  
Jung Hee Shim ◽  
...  

Abstract Melanoma is visible unlike other types of cancer, but it is still challenging to diagnose correctly because of the difficulty in distinguishing between benign nevus and melanoma. We conducted a robust investigation of melanoma, identifying considerable differences in local elastic properties between nevus and melanoma tissues by using atomic force microscopy (AFM) indentation of histological specimens. Specifically, the histograms of the elasticity of melanoma displayed multimodal Gaussian distributions, exhibiting the heterogeneous mechanical properties, in contrast with the unimodal distributions of elasticity in the benign nevus. We identified this notable signature was consistent regardless of blotch incidence by sex, age, anatomical site (e.g., thigh, calf, arm, eyelid, and cheek), or cancer stage (I, IV, and V). In addition, we found that the non-linearity of the force-distance curves for melanoma is increased compared to benign nevus. We believe that AFM indentation of histological specimens may technically complement conventional histopathological analysis for earlier and more precise melanoma detection.


Medicina ◽  
2021 ◽  
Vol 57 (12) ◽  
pp. 1361
Author(s):  
Shogo Shinohara ◽  
Masahiro Kikuchi ◽  
Hiroyuki Harada ◽  
Kiyomi Hamaguchi ◽  
Ryo Asato ◽  
...  

Background and Objectives: To investigate clinicopathological characteristics and survival outcomes of patients with buccal cancer in Japan. Materials and Methods: This study was conducted using a database of 1055 patients with oral cancers treated between 2010 and 2017 at 12 institutions in Japan. Ninety-two patients (8.7%) with primary buccal cancer were extracted and clinicopathological characteristics and survival outcomes were compared between patients with buccal cancers and patients with other oral cancers. Results: Ages were significantly higher in the patients with buccal cancer (73 years old vs. 69 years old). Buccal cancer had less advanced cT stage and cN stage than other oral cancers. Overall 5-year survival (OS) was 80.6%, and recurrence-free 5-year survival (RFS) of buccal cancers was 67.8%, and there were no significant differences in survival compared with other oral cancers in terms OS or RFS (5y-OS: 82.5%, 5y-RFS: 74.4%). However, patients with stage IV buccal cancer showed poorer prognosis in terms of OS and RFS compared with the same stage patients with other oral cancer. Advanced T stage was the only factor independently associated with both OS and RFS of patients with buccal cancer in this study. Conclusions: Postoperative radiotherapy or chemoradiotherapy should be considered to improve survival outcome of buccal cancer patients, especially for the patients with advanced primary site disease or a higher cancer stage.


Sign in / Sign up

Export Citation Format

Share Document